Grants of up to $10,000 to support new mass spectrometry projects and methodologies in emerging proteomics technology areas in support of early phase investigations and pilot studies.
Sarafan ChEM-H seeks to support small teams of clinicians and molecular scientists/engineers who seek to test bold hypotheses or validate the utility of a new tool in disease diagnosis or management using samples from human subjects.
SCI offers Innovation Awards to support collaborative projects focused on acceleration of basic, translational, clinical and population-based cancer research, and projects focused on cancer care, such as pancreatic, breast and gynecologic cancers.
The Innovative Medicines Accelerator seeks to accelerate the prototyping of innovative early-stage translational stem cell and gene therapies that address unmet clinical needs.
The WHSDM Center aims to promote health research on biological sex differences, women’s health, and sexual and gender minority health at the School of Medicine, and to foster collaborations on these topics across SoM depts and the University.
DUE: October 24th The Neuroscience:Translate program supports translational research addressing unmet needs in any area of neuroscience. Resulting technologies & therapies are intended to lead to licensing exits to eventually reach the patient.
The Stanford Cancer Institute, Population Sciences Program and Community Outreach and Engagement, and the Center for Population Health Sciences are pleased to offer a call for cancer health equity proposals.
The Innovative Medicines Accelerator (IMA) is accepting proposals that address two major challenges in drug development: identifying drug leads and optimizing drug prototypes.
The Canary Center for cancer early detection will offer a 1-year graduate fellowship in collaboration with the International Alliance for Cancer Early Detection (ACED).
